Apr 12 |
Eli Lilly, Novo Euphoria Risks Disappointing Investors, Goldman Says
|
Apr 12 |
Shark Tank's Mark Cuban speaks out on weight-loss drugs
|
Apr 12 |
GLP-1s benefit Parkinson’s: Barclays sees implications across biopharma
|
Apr 12 |
European regulator concludes no suicide link to obesity drugs
|
Apr 12 |
No link between weight loss drugs and suicidal thoughts, EU regulator concludes
|
Apr 11 |
Roche, Eli Lilly gain FDA breakthrough device tag for Alzheimer's blood test
|
Apr 10 |
3 Obesity Drug Stocks Set to Skyrocket as Demand Goes Wild
|
Apr 10 |
Insiders are Piling into These 10 Healthcare Stocks in 2024
|
Apr 10 |
This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?
|
Apr 10 |
Jim Cramer Stands By Nvidia And Eli Lilly Despite Market Dips, Says 'Terrific Time To Take Some Profits'
|